Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Empower Clinics Inc. C.EPW

Alternate Symbol(s):  EPWCF

Empower Clinics Inc. is a Canada-based integrated healthcare and medical device company with multi-disciplinary clinics. The Company provides body and mind wellness for patients through its medical clinics, digital and telemedicine care, medical diagnostics laboratories, and sale of medical devices. Its segments include Health & Wellness, comprising clinic operations, patient visits, and... see more

CSE:EPW - Post Discussion

Empower Clinics Inc. > Counter Intuitive
View:
Post by Smokey1958 on May 16, 2022 9:22am

Counter Intuitive

While the forces that have driven down the sp of Empower are in part self inflected what is the advantage, even to day traders, of supporting this? In the most recent interview Steve alludes to the fact that a falling sp impacts the dynamic of the 8 clinic acquisition. Presumably part of this transaction involved the acquiring of Empower shares ....the number of which constantly changes with such volatility in the sp. It then becomes a circular problem as the company can't demonstrate adequate growth to maintain a more positive outlook for those holding long and new investors.

Adding to this the problems associated with releasing timely audited financials ( not unique to CBDT by the way), bleeding on the markets and some issues, now resolved, to get Kai Medical back on track  and it should be no surprise that the sp has taken a dive. In the end does this have a longterm impact on the vision of the company ....the unequivocal answer should be no. The next few months should provide answers with much more clarity.

In the meantime Morningstar's Fair Value sp remains above $.30 and the stock is not considered to be significantly overvalued (and overbought) until it reaches $2.00. Hopefully the annual financials for 2021 and quarterly finacials for early 2022, which will likely be released close to each other now will offer a catalyst to meet these valuations.

GLTE!!!
Comment by Shlinker_ on May 16, 2022 4:10pm
That's your problem right there, having faith in Morningstar and Steve. Good luck with that dumb one.
Comment by Smokey1958 on May 16, 2022 4:36pm
Where did you arrive from ...poor little soul? 178 pages of posts at 20 posts per page since 2011 and you still haven't found a friend or something useful to express. That's a tremendous amount of practice with so little return. As a friendly suggestion you might consider a more authentic and rewarding pastime. You're not very good at this! Cheers and best of luck to you ...more  
Comment by Shlinker_ on May 16, 2022 11:15pm
I'm better at this than you are at investing, clearly.
Comment by HedgeFund001 on May 16, 2022 5:44pm
Smokey are you still on here ?? For the past year you have been trying to sound like you know something about investing but every time you open your mouth reality make you look like a fool.   Paid Pumpers are not welcome on here.. GO AWAY !!  ( Take All your AKAs with you )
Comment by Shlinker_ on May 16, 2022 11:16pm
I wonder if his real name is George....
Comment by RackiTUP on May 17, 2022 9:24am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities